| WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)

WHO Public Assessment Reports (WHOPARs) published

Announcement

10 November, 2022 - 14:40 (CET)

WHO Public Assessment Reports (WHOPARs) published

Announcement

9 November, 2022 - 12:57 (CET)

WHO Public Assessment Reports (WHOPARs) published

Announcement

9 November, 2022 - 12:54 (CET)

Independent Performance Evaluation for SARS-COV-2 Antigen RDTS

IVD

Announcement

9 November, 2022 - 11:10 (CET)

WHO PQT in collaboration with PATH and FIND will perform an independent performance evaluation to generate additional performance data for RDTs that are undergoing EUL assessment and for those that

Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process updated

Announcement

9 November, 2022

WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated

IVD

Announcement

8 November, 2022 - 21:00 (CET)

List of IVDs that have received WHO Emergency Use Listing for SARS-CoV-2 updated

IVD

Announcement

8 November, 2022 - 17:45 (CET)

Macleods’ Pyrimethamine/Sulfadoxine + Amodiaquine (hydrochloride) dispersible tablets prequalified

Announcement

4 November, 2022 - 22:00 (CET)

WHO Prequalification Unit (PQT) added the below new product to its prequalified list:

New WHO Public Inspection Reports (WHOPIRs) published

Announcement

4 November, 2022 - 17:20 (CET)

List of IVDs that have received WHO Emergency Use Listing for SARS-CoV-2 updated

IVD

Announcement

3 November, 2022 - 21:00 (CET)

Subscribe to